Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer

14 Jul 2021

Abstract excerpt

Background and objectives: Receptor-interacting serine/threonine-protein kinase-2 (RIPK2) is an important mediator in different pathways in the immune and inflammatory response system. RIPK2 was also shown to play different roles in different cancer types; however, in colorectal cancer (CRC), its role is not well established. This study aims at identifying the role of RIPK2 in CRC progression and survival....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Colorectal Cancer Treatments and Studies
Share to Inflammatory mediators and NSAID effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34356990
DOI: 10.3390/medicina57070709

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal CancerPMID 34356990Read ↗

Pan-Cancer Analysis Reveals RIPK2 Predicts Prognosis and Promotes Immune Therapy Resistance Via Triggering Cytotoxic T Lymphocytes DysfunctionSemantic proximity Read ↗

Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunctionSemantic proximity Read ↗

High Expression of RIPK2 is Associated with Taxol Resistance in Serous Ovarian CancerSemantic proximity Read ↗

LIMK1: A Promising Prognostic and Immune Infiltration Indicator in Colorectal CancerSemantic proximity Read ↗

Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian CancerSemantic proximity Read ↗

Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphorylationSemantic proximity Read ↗

A Pan-Cancer Analysis of IRAK1 Expression and Their Association With Immunotherapy ResponseSemantic proximity Read ↗

Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlasSemantic proximity Read ↗

IFITM2 is a prognostic in colorectal cancer and promotes progression by activating PI3K/AKT pathwaySemantic proximity Read ↗

Human pan-cancer analysis of the predictive biomarker for the tumor necrosis factor-alpha-induced protein 8-like 2 (TNFAIP8L2)Semantic proximity Read ↗

NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent mannerSemantic proximity Read ↗

A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.